MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1086/644768

Медицинская библиотека · Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2009

Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America.

Deeks Steven G, Gange Stephen J, Kitahata Mari M, Saag Michael S, Justice Amy C, Hogg Robert S, Eron Joseph J, Brooks John T, Rourke Sean B, Gill M John, Bosch Ronald J, Benson Constance A, Collier Ann C, Martin Jeffrey N, Klein Marina B, Jacobson Lisa P, Rodriguez Benigno, Sterling Timothy R, Kirk Gregory D, Napravnik Sonia, Rachlis Anita R, Calzavara Liviana M, Horberg Michael A, Silverberg Michael J, Gebo Kelly A, Kushel Margot B, Goedert James J, McKaig Rosemary G, Moore Richard D

СтатьяПоддержка NIH: внешняя программаПеревод в очереди

Аннотация

BACKGROUND

Although combination antiretroviral therapy continues to evolve, with potentially more effective options emerging each year, the ability of therapy to prevent multiple regimen failure and mortality in clinical practice remains poorly defined.

METHODS

Sixteen cohorts representing over 60 sites contributed data on all individuals who initiated combination antiretroviral therapy. We identified those individuals who experienced virologic failure (defined as a human immunodeficiency virus [HIV] RNA level >1000 copies/mL), received modified therapy, and subsequently had a second episode of virologic failure. Multivariate Cox regression was used to assess factors associated with time to second regimen failure and the time to death after the onset of second regimen failure.

RESULTS

Of the 42,790 individuals who received therapy, 7159 experienced a second virologic failure. The risk of second virologic failure decreased from 1996 (56 cases per 100 person-years) through 2005 (16 cases per 100 person-years; P < .001). The cumulative mortality after onset of second virologic failure was 26% at 5 years and decreased over time. A history of AIDS, a lower CD4(+) T cell count, and a higher plasma HIV RNA level were each independently associated with mortality. Similar trends were observed when analysis was limited to the subset of previously treatment-naive patients

CONCLUSIONS

Although the rates of multiple regimen failure have decreased dramatically over the past decade, mortality rates for those who have experienced failure of at least 2 regimens have remained high. Plasma HIV RNA levels, CD4(+) T cell counts at time of treatment failure, and a history of AIDS remain independent risk factors for death, which emphasizes that these factors remain important targets for those in need of more-aggressive therapeutic interventions.

Для цитирования: Deeks Steven G, Gange Stephen J, Kitahata Mari M, Saag Michael S, Justice Amy C, Hogg Robert S, Eron Joseph J, Brooks John T, Rourke Sean B, Gill M John, Bosch Ronald J, Benson Constance A, Collier Ann C, Martin Jeffrey N, Klein Marina B, Jacobson Lisa P, Rodriguez Benigno, Sterling Timothy R, Kirk Gregory D, Napravnik Sonia, Rachlis Anita R, Calzavara Liviana M, Horberg Michael A, Silverberg Michael J, Gebo Kelly A, Kushel Margot B, Goedert James J, McKaig Rosemary G, Moore Richard D. Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2009. DOI: 10.1086/644768.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.